PreveCeutical targets up to $600,000 in C$0.03-per-unit private placement
Bitget2026/09/28 21:00- PreveCeutical launched a non-brokered private placement of up to 20,000,000 units at $0.03 per unit to raise up to $600,000.
- Each unit includes 1 common share, 0.5 warrant; each whole warrant exercisable at $0.06 for two years.
- Warrant expiry can be accelerated if the CSE closing price is $0.11 or higher for 10 straight trading days.
- Proceeds earmarked for short-loan repayments, professional fees, patents, further studies, and general working capital.
- Securities will be unregistered under the U.S. Securities Act; resale restrictions include a four-month-and-one-day hold period.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Is AI an engine or a killer? Morgan Stanley provides answers with data: productivity soars, but nearly 90% of the benefits are taken by 12 industries
Morgan Stanley stated that the productivity dividends from AI are concentrated in 12 highly exposed industries, with growth rates reaching twice the twenty-year average. For the first time, signs of job replacement have emerged.

Production Increase Falls Short, Layoffs First! Boeing (BA.US) Cuts 5% of Commercial Airplane Jobs, Delays 737 Monthly Production Target of 47 Aircraft to 2027
Stephanie Pope, head of Boeing's commercial airplanes division, informed employees in an internal memo on Monday that due to obstacles in increasing aircraft production, the division plans to cut 5% of its workforce.